This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holder, I. A.
Right arrow Articles by Frank, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holder, I. A.
Right arrow Articles by Frank, D. W.

 Previous Article  |  Next Article 

Infection and Immunity, September 2001, p. 5908-5910, Vol. 69, No. 9
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.9.5908-5910.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

PcrV Immunization Enhances Survival of Burned Pseudomonas aeruginosa-Infected Mice

Ian Alan Holder,1,* Alice N. Neely,1 and Dara W. Frank2

Shriners Hospital for Children, Cincinnati, Ohio,1 and Medical College of Wisconsin, Milwaukee, Wisconsin2

Received 2 March 2001/Returned for modification 18 April 2001/Accepted 15 June 2001

Burned Pseudomonas aeruginosa-infected mice immunized against PcrV, a type III virulence system translocating protein, showed significantly enhanced survival compared to controls. Survival was non-O serotype specific and correlated with a reduced systemic microbial load. Infection with a high-level toxin A-producing strain required supplemental antitoxin treatment to enhance survival.


* Corresponding author. Mailing address: Department of Microbiology, Shriners Hospital for Children, 3229 Burnet Ave., Cincinnati, OH 45229. Phone: (513) 872-6350. Fax: (513) 872-6999. E-mail: iaholder{at}juno.com.


Infection and Immunity, September 2001, p. 5908-5910, Vol. 69, No. 9
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.9.5908-5910.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Wesselkamper, S. C., Eppert, B. L., Motz, G. T., Lau, G. W., Hassett, D. J., Borchers, M. T. (2008). NKG2D Is Critical for NK Cell Activation in Host Defense against Pseudomonas aeruginosa Respiratory Infection. J. Immunol. 181: 5481-5489 [Abstract] [Full Text]  
  • Caroline, G., Eric, F., Bohn, Y.-S. T., Sylvie, E., Attree, I. (2008). Oligomerization of PcrV and LcrV, Protective Antigens of Pseudomonas aeruginosa and Yersinia pestis. J. Biol. Chem. 283: 23940-23949 [Abstract] [Full Text]  
  • Zolfaghar, I., Evans, D. J., Ronaghi, R., Fleiszig, S. M. J. (2006). Type III Secretion-Dependent Modulation of Innate Immunity as One of Multiple Factors Regulated by Pseudomonas aeruginosa RetS. Infect. Immun. 74: 3880-3889 [Abstract] [Full Text]  
  • Priebe, G. P., Meluleni, G. J., Coleman, F. T., Goldberg, J. B., Pier, G. B. (2003). Protection against Fatal Pseudomonas aeruginosa Pneumonia in Mice after Nasal Immunization with a Live, Attenuated aroA Deletion Mutant. Infect. Immun. 71: 1453-1461 [Abstract] [Full Text]